Paradigm Biopharmaceuticals Ltd.ASX: PAR

Phase 2 Synovial Fluid Biomarker Study Update

Oct 26, 2021 at 2:42 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment